Status:
NOT_YET_RECRUITING
A Clinical Observational Study Evaluating the Efficacy of Cerave Neuroceramide Intensive Repair Body Lotion .
Lead Sponsor:
ChinaNorm
Conditions:
Dry Skin in the Elderly
Eligibility:
All Genders
55+ years
Brief Summary
This study is a single-center observational clinical study aimed at evaluating the impact of Cerave Neuroceramide Moisturizing Repair Body Lotion on the quality of life, improvement in skin condition,...
Eligibility Criteria
Inclusion
- Individuals with moderate to severe skin dryness as assessed by a clinician (ODS score of 2 or 3)
- Individuals with moderate to severe self-reported skin itching as assessed by a clinician (NRS ≥ 1)
- Individuals aged 55 years and older
- Open to patients with one or more of the following conditions:
- History of atopic dermatitis;
- Currently using a stable medication regimen prescribed and monitored by a physician (ongoing use), where the medication has side effects causing skin dryness (e.g., statins, calcium channel blockers, diuretics, antiplatelet agents, ACE inhibitors, beta-blockers, adrenergic receptor agonists, immunosuppressants, etc.);
- Patients with systemic diseases associated with dryness (diagnosed and managed by a physician), such as diabetes, hyperthyroidism, hypothyroidism, or hemodialysis.
- Voluntarily participate in the trial, understand and agree to sign the informed consent form, and agree to follow the study protocol throughout the study period, including using the study-provided products, not using other similar products, completing a diary, and attending regular follow-up visits as required by the trial.
Exclusion
- Individuals with a history of allergy, allergic reaction, or hypersensitivity to any component of the study product (Cerave Neuroceramide Moisturizing Repair Body Lotion);
- Individuals with a history of allergic contact dermatitis secondary to the use of moisturizing products;
- Individuals with any clinical manifestations or other conditions at the treatment site that the physician deems may affect the evaluation or results of the study product;
- Individuals who are unable or unwilling to attend all study visits and adhere to the treatment regimen;
- Individuals who have participated in any other drug clinical studies within the past 3 months prior to the start of the trial.
Key Trial Info
Start Date :
August 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT07133971
Start Date
August 22 2025
End Date
January 1 2026
Last Update
August 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.